Advertisement

RDNT

RadNet, Inc.

Healthcare · USD

Set alert

Price alert · RDNT

All alert types
73.49 USD -0.16 -0.22%
As of Oct 30, 2026 Extended hours 73.09 -0.54%
Bid
73.50 × 2
Ask
73.59 × 2
71.92 Day range 74.25
51.87 52-week range 84.48
YTD
+3.00%
1 year
-3.43%
Open
73.60
Prev close
73.65
Mkt cap
5.78B
Vol
571.70K
Avg vol
675.23K
EPS
-0.27
P/E
0.00
Div yield
0.00%
More statistics
Low
71.92
High
74.25
Forward P/E
89.50
Beta
1.41
Short ratio
13.29
Inst. own
106.03%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
72.63
200-d avg
65.14
1y target
94.63

5D chart

Chart tools
Interval
RDNT five-day price chart69.871.172.473.775.0Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
5.78B
Enterprise value
7.55B
Trailing P/E
0.00
Forward P/E
89.50
PEG ratio
0.96
Price / sales
2.55
Price / book
5.27
EPS (TTM)
-0.27
Beta
1.41
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-0.93%
Revenue (TTM)
2.27B
Revenue growth
25.00%
Free cash flow
157.74M
Total cash
726.27M
Total debt
2.18B
Return on equity
1.50%
Shares outstanding
78.70M
Short % of float
13.62%
50-day average
72.63
200-day average
65.14

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 94.63 +28.8% upside
Target (low)
79.00
Target (mean)
94.63
Target (high)
105.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Nov 9, 2026

Expected Nov 9, 2026. Consensus EPS estimate 0.22143.

Earnings history

Financials — quick view

All financials
RDNT Revenue — quarterly 622.72M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
RDNT Net income — quarterly 7.53M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
RDNT EPS — quarterly 0.10
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

RDNT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 9, 2026Sep 30, 20260.2214———
Aug 9, 2026Jun 30, 20260.20140.29+0.09+43.99%
May 11, 2026Mar 31, 2026-0.14-0.28-0.14-100.00%
Mar 2, 2026Dec 31, 20250.190.23+0.04+21.05%
Nov 10, 2025Sep 30, 20250.22290.20-0.02-10.27%
Aug 11, 2025Jun 30, 20250.170.31+0.14+82.35%

Upgrades / downgrades

RDNT analyst upgrades and downgrades
DateFirmActionFromTo
Aug 28, 2026BarclaysmainOverweightOverweight
Aug 11, 2026Truist SecuritiesmainBuyBuy
May 20, 2026BarclaysmainOverweightOverweight
Apr 21, 2026BarclaysmainOverweightOverweight
Jan 9, 2026Keybancinit—Overweight
Dec 1, 2025B. Riley SecuritiesmainBuyBuy

About RadNet, Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
radnet.com

News

Your note

Sign in to keep a note on RDNT — it syncs with the Stock Master app.

Insider holders

RDNT insider holders
InsiderRelationLatest transactionDateShares held
BERGER HOWARD G FRANChief Executive OfficerStock GiftJun 15, 20260
FORTHUBER STEPHEN MOfficerSaleJun 14, 2026507,199
HAMES NORMAN ROfficerStock Award(Grant)Mar 2, 20260
JAYANATHAN RANJANChief Technology OfficerSaleAug 18, 2025138,198
KATZ DAVID JEFFREYOfficerStock Award(Grant)Mar 2, 202690,866
LEVITT LAWRENCE LDirectorStock Award(Grant)Jun 1, 2026167,902

Institution ownership

RDNT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.13.92%10,957,808804.19MJun 29, 2026
RTW Investments LP6.16%4,846,958355.72MJun 29, 2026
Price (T.Rowe) Associates Inc5.72%4,501,195330.34MJun 29, 2026
Vanguard Portfolio Management LLC5.17%4,066,931298.47MJun 29, 2026
Vanguard Capital Management LLC4.06%3,193,565234.38MJun 29, 2026
Beck, Mack & Oliver LLC4.02%3,163,592232.18MJun 29, 2026

Fund ownership

RDNT fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF4.47%3,513,849257.88MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.86%2,252,511165.31MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.35%1,850,746135.83MSep 29, 2026
T. Rowe Price Mid-Cap Value Fund, Inc.2.23%1,756,598128.92MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.06%1,623,822119.17MJun 29, 2026
ETF Series Solutions-Defiance Quantum ETF1.45%1,143,62283.93MJun 29, 2026
Advertisement